Divi's Laboratories (BOM:532488) Net Income From Continuing Operations : ₹21,910 Mil (TTM As of Mar. 2025)

View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Divi's Laboratories's net income from continuing operations for the three months ended in Mar. 2025 was ₹6,620 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ₹21,910 Mil.

Divi's Laboratories Net Income From Continuing Operations Historical Data

The historical data trend for Divi's Laboratories's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Net Income From Continuing Operations Chart

Divi's Laboratories Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Income From Continuing Operations

Get a 7-Day Free Trial

26,660.40

36,835.00

23,690.00

21,630.00

29,160.00

Divi's Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															5,380.00	4,300.00	5,100.00	5,890.00	6,620.00

Divi's Laboratories Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹21,910 Mil.

Divi's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (BOM:532488) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

DIVISLAB:India

Address

Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032

Website

https://www.divislabs.com

Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines